Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2001
11/01/2001WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001WO2001081295A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001WO2001081274A1 Process for producing substituted aromatic compound
11/01/2001WO2001080844A2 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
11/01/2001WO2001041762A3 Valdecoxib compositions
11/01/2001WO2001041761A3 Valdecoxib compositions
11/01/2001WO2001010847A3 Novel integrin receptor antagonists
11/01/2001WO2001007497A3 Performance of energy storage devices: potential areas for dendritic chemistry involvement
11/01/2001US20010037042 Using monophosphine palladium complex catalyst
11/01/2001US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001US20010037028 Acrylates having high degree of halogenation and polymers using these monomers; useful for optical waveguides and telecommunication
11/01/2001US20010037025 Benzopyran, benzothiopyran or benzoquinone derivatives are useful in the treatment of ailments and disorders where a reduction of blood glucose is benefical, such as diabetes
11/01/2001US20010036924 Dietetics, immunomodulator, antiinflammatory agents
11/01/2001CA2407663A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001CA2407662A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001CA2407093A1 Substituted phenyl farnesyltransferase inhibitors
11/01/2001CA2406272A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001CA2365320A1 Novel heterocyclic compounds
10/2001
10/31/2001EP1149885A1 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149069A1 Phenylglycine derivatives
10/31/2001EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001CN1319599A Process for preparing imidazolinone
10/31/2001CN1319587A Heterocyclonitrogen heteroethane derivant with antiviral activity
10/31/2001CN1319579A Use of 1,1-di(4-chlorophenyl-2,2,2-trichloroalcohol adduct
10/31/2001CN1319578A Use of 1,1-di (4-chlorophenyl)-2,2,2-trichloroalcohol adduct
10/30/2001US6310238 Intermediates for the preparation of polybenzoxazoles and polybenzothiazoles
10/30/2001US6310214 Process for the preparation of chloropyridine sulphonic acid chlorides
10/30/2001US6310107 (+)-6-(4-biphenylyl)methoxy-2-(2-(n,n-dimethylamino)ethyl)tetr alin, or a salt is useful for inhibiting production and/or secretion of amyloid-beta protein
10/30/2001US6310096 Cyclohexadiene-derivatives as pesticides
10/30/2001US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/30/2001US6310060 For use as antiproliferative agent for use against cancer, psoriasis, restenosis, autoimmune disease, or atherosclerosis
10/30/2001CA2048931C Carbamoyl-1-(pyridinylalkyl)-1h-indoles, indolines and related analogs
10/25/2001WO2001079262A1 Pyrazinone and pyridinone derivatives as thrombin inhibitors
10/25/2001WO2001079195A2 Pyridine and pyrazine derivatives as thrombin inhibitors
10/25/2001WO2001079194A1 Method for obtaining derivatives of [[(pyridil substituted)methyl]thio]benzimidazol
10/25/2001WO2001079189A2 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/25/2001WO2001079175A1 Synthesis of intermediates useful in preparing tricyclic compounds
10/25/2001WO2001079174A1 A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
10/25/2001WO2001079173A2 Enamine derivatives as cell adhesion molecules
10/25/2001WO2001079172A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
10/25/2001WO2001079161A1 NOVEL α-SULFIN- AND α-SULFONAMINO ACID AMIDE DERIVATIVES
10/25/2001WO2001079160A1 Alpha-sulfin- and alpha-sulfonamino acid amide derivatives
10/25/2001WO2001079159A1 NOVEL α-SULFIN- AND α-SULFONAMINO ACID AMIDES
10/25/2001WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001WO2001078733A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
10/25/2001WO2001078728A1 Acetylcholinesterase inhibitors containing 1-benzyl- pyridinium salts
10/25/2001WO2001078648A2 6-methylnicotinamide derivatives as antiviral agents
10/25/2001WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001WO2001027113A3 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES
10/25/2001WO2001019798A3 Inhibitors of factor xa
10/25/2001US20010034464 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst
10/25/2001US20010034450 Tetra-substituted phenyl derivatives and processes for their preparation
10/25/2001US20010034448 New compounds, their preparation and use
10/25/2001US20010034447 N-(5-tert-butyl-2-methoxyphenyl)-n'-(4-(1-oxoisoindolin-5-ylox y)penyl)urea as anticarcinogenic agents
10/25/2001US20010034445 Compounds such as 3-(3,4-Dihydro-8-((((6-amino2-pyridinyl) methyl)methylamino)carbonyl)-1-methyl-2,5-dioxo-1h-1,4-benzo diazepine)4-propanoic acid used as antiinflammatories, anticarcinogenics, and to treat angiogenesis, restenosis, etc
10/25/2001US20010034364 Isoprenoid pathway inhibitors for stimulating bone growth
10/25/2001US20010034357 Substituted pyridine compounds useful for controlling chemical synaptic transmission
10/25/2001US20010034348 Nitric oxide synthase inhibitor; nervous system disorders
10/25/2001US20010034342 Brain disorders, antiischeic agents
10/25/2001CA2406903A1 Alpha-sulfin- and alpha-sulfonamino acid amide derivatives
10/25/2001CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001CA2404263A1 Novel .alpha.-sulfin- and .alpha.-sulfonamino acid amide derivatives
10/25/2001CA2403563A1 Novel .alpha.-sulfin- and .alpha.-sulfonamino acid amides
10/24/2001EP1148048A2 Polyaromatic antiviral compositions
10/24/2001EP1147162A1 Ferroelectric active matrix displays with wide operating temperature range
10/24/2001EP1147102A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001EP1147086A1 Compositions for the treatment of skin diseases
10/24/2001EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/24/2001EP1147079A2 Beta-phenylalanine derivatives as integrin antagonists
10/24/2001EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response
10/24/2001EP1146866A1 A method for treating patients with acne by administering a cyclic gmp pde inhibitor
10/24/2001EP0970050B1 Process for the preparation of 10,11-dihydro-5h-dibenzo a,d]cyclohept-5-enes and derivatives thereof
10/24/2001EP0840717B1 Preparation of aldehydes or ketones from alcohols
10/24/2001EP0835246B1 Aromatic compounds and pharmaceutical compositions containing them
10/24/2001EP0749419B1 Oxime derivatives and their use as pesticides
10/24/2001EP0648212B1 Benzoxazole and benzothiazole derivatives as pharmaceutical
10/24/2001CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001CN1319091A Cyanophenyl derivatives
10/24/2001CN1319086A Anthranilic acid derivatives
10/24/2001CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
10/24/2001CN1318535A Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
10/24/2001CN1073553C Process for producing N-arylhydroxylamines and N-hetarylhydroxylamines
10/24/2001CN1073551C Ethenyl amide compound prodn process
10/23/2001US6307087 Ligands for metals and improved metal-catalyzed processes based thereon
10/23/2001US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/23/2001US6307054 Process for preparing 2,4- dihydroxypyridine and 2,4- dihydroxy-3-nitropyridine
10/23/2001US6306884 Benzamidine derivatives and their use as anti-coagulants
10/23/2001US6306881 Anti-inflammatory agents
10/23/2001US6306873 Substituted β-thiocarboxylic acids
10/23/2001US6306871 Iodonitrobenzamide derivatives as anticarcinogenic, antitumor agents and viricides
10/23/2001US6306860 2,5-pyridinedicarboxylic acid derivatives
10/23/2001US6306840 Cell adhesion inhibitors
10/23/2001CA2083179C Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
10/18/2001WO2001077650A1 Analyte detection & apparatus therefor
10/18/2001WO2001077079A2 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
1 ... 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 ... 633